- Disease
- Abnormal immune responses
- Acute myeloid leukemia
- Adrenal cortex carcinoma
- Advanced Renal Cell Carcinoma (RCC)
- Aggressive Systemic Mastocytosis (ASM)
- Anemia due to chronic kidney disease (CKD)
- Anemia in Chronic Kidney Disease (CKD) Patients on Dialysis
- ATTR-CM
- B-cell malignancies
- BRAF V600E or V600K mutation-positive metastatic melanoma.
- Breast Cancer
- Broad-spectrum anti-cancer drug
- Broad-spectrum antitumor agents
- Carcinoma of bile duct
- Cardiovascular Disease
- Cholangiocarcinoma with FGFR2 gene fusion
- Cholestatic liver diseases
- chronic fibrosing interstitial lung diseases (ILDs)
- Chronic graft-versus-host disease
- Chronic Hepatitis B
- Chronic immune (idiopathic) thrombocytopenic purpura
- Chronic immune disorders
- Chronic kidney disease
- Chronic liver disease
- Chronic Liver Disease with Thrombocytopenia
- Chronic Lymphocytic Leukemia,SLL,MCL
- Chronic Myelogenous Leukemia (CML)
- Colorectal cancer
- desmoid tumors in adults
- Desmoid-Type Fibromatosis
- Diarrhea
- Diffuse midline glioma (DMG) with H3K27M mutation.
- Endometrial carcinoma
- Endometriosis pain
- Epileptic seizures
- Epithelioid Sarcoma
- Erdheim Chester Disease
- Essential hypertension
- FLT3 mutation AML
- Follicular Lymphoma
- Gastrointestinal Stromal Tumors (GISTs)
- Hepatitis C (HCV)
- Hepatocellular Carcinoma (HCC)
- HER2-Negative Breast Cancer
- HER2-Positive breast cancer
- heterozygous familial hypercholesterolemia (HeFH)
- High-risk myelofibrosis
- hormone receptor-positive (HR+)
- HR-Positive
- Hronic myeloid leukemia (Ph+ CML) in chronic phase (CP)
- Human Immunodeficiency Virus (HIV)
- Hyperlipidemia
- Hyperprolactinemia
- Hypertrophic Cardiomyopathy (oHCM)
- IDH1-Mutant Gliomas
- Idiopathic Pulmonary Fibrosis (IPF)
- IgA Nephropathy
- influenza A and influenza B
- Insomnia
- Kidney Disease
- Large B-cell lymphoma
- leukaemia
- Lymphoma
- Medullary thyroid cancer (MTC)
- Melanoma
- Metastatic colorectal cancer,GISTs
- Metastatic melanoma with BRAF V600E mutation
- Metastatic non-small cell lung cancer (NSCLC)
- Metastatic Pancreatic Adenocarcinoma
- Metastatic urothelial carcinoma
- Multiple myeloma
- Myeloma
- Myeloproliferative Disorders
- Neurofibromatosis
- Non-small Cell Lung cancer(NSCLC)
- Nonalcoholic steatohepatitis (NASH)
- Other cancers
- Other IDH1-Mutated Cancer
- Ovarian cancer
- Parkinson's Disease
- partial epilepsy patients aged 2 years and above
- Plaque psoriasis
- Positive acute myeloid leukemia
- postmenopausal women men with breast cancer
- Prevention of cytomegalovirus (CMV) infection and disease
- Primary Biliary Cholangitis (PBC)
- Primary immunoglobulin A nephropathy
- Prolactinomas
- Prostate cancer
- Psoriatic Arthritis
- Pulmonary Arterial Hypertension (PAH)
- Pulmonary MDR/XDR-TB
- Rare Diseases
- Renal Cell Carcinoma
- Resistant Hypertension
- Rheumatoid Arthritis
- Small Cell Lung Cancer
- Small lymphocytic lymphoma (SLL)
- Soft Tissue Sarcoma (STS)
- Soft Tissue Tumors
- Solid Tumors
- Thyroid Cancer
- Transthyretin amyloidosis
- Treat atopic dermatitis
- Treat diseases caused by excessive androgens
- Treat essential thrombocythemia (ET)
- Treat overactive bladder
- Treat RET gene fusion positive NSCLC and MTC
- Treatment of chronic heart failure
- Treatment of Neuropathic Pain
- Treatment of non-cystic fibrosis bronchiectasis (NCFB)
- Type 1 neurofibromatosis
- Type 2 diabetes Mellitus
- Urothelial carcinoma
- Valcyte treatment for cytomegalovirus infection
- Vasomotor Symptoms Of Menopause
- Weight Loss
Related News
-
LuciDarax Side Effects, Clinical Trials & FAQs
Introduction Starting treatment for metastatic pancreatic cancer involves more than understanding how…
2026-10-08
-
LuciDarax (Daraxonrasib) Dosage and Administration: A Patient-Friendly Safety Guide
Introduction Starting an oral cancer treatment can feel overwhelming. Patients may have…
2026-10-08
-
LuciDarax (Daraxonrasib): Understanding Its Role in RAS-Driven Pancreatic Cancer
Introduction A diagnosis of metastatic pancreatic cancer can bring difficult treatment decisions…
2026-10-08
-
LuciDarax (Daraxonrasib) Clinical Trials, Distribution & Value in Precision Oncology
Clinical Trials of LuciDarax (Daraxonrasib) The clinical development of LuciDarax (Daraxonrasib) has…
2026-10-05
-
RASONQUE™(Daraxonrasib): Dosage Instructions, Side Effects, FAQ & Myths
How to Take RASONQUE™ (Daraxonrasib) Safely and Effectively Take it exactly as…
2026-10-03
-
Turning Off the Signal That Fuels Cancer: RASONQUE™ (Daraxonrasib) Overview
Turning Off the Signal That Fuels Cancer: RASONQUE™ (Daraxonrasib) Overview When Every…
2026-10-01
